Keros Therapeutics Inc (KROS) support and resistance · rev $32.0K
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
This page maps Keros Therapeutics Inc (KROS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
KROS currently screens at market cap $208.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new KROS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the KROS quote page for the session range and the stock page for the full model.
Not investment advice.